Health
SK Bioscience starts developing vaccine against Covid-19 variants – Korea Biomedical Review
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness…
SK Bioscience said that it has set about to develop a vaccine to cope with Covid-19 variants with financial support from the Coalition for Epidemic Preparedness Innovations (CEPI), an international private organization.
The Korean company will receive up to $14.2 million (about 16 billion won) in research and development funds from CEPI to develop Covid-19 mutants using the development platform of GBP510, for which clinical trials are now underway.
SK Bioscience said it had also received additional…
-
General16 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Noosa News23 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
General21 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Noosa News23 hours ago‘The Book of Mormon’ Returns to Melbourne and Brisbane in 2026